伊克力西斯(EXEL)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

EXEL 伊克力西斯

盘后交易 05-01 19:26:54 EDT

21.93

-1.53

-6.54%

盘后21.92

+0.00-0.02%

19:05 EDT

最高22.24	最低20.69	成交量747.16万
今开21.64	昨收23.46	日振幅6.61%
总市值64.63亿	流通市值54.23亿	总股本2.95亿
成交额1.61亿	换手率3.02%	流通股本2.47亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"EXEL","market":"US","secType":"STK","nameCN":"伊克力西斯","latestPrice":21.925,"timestamp":1714593600000,"preClose":23.46,"halted":0,"volume":7471581,"hourTrading":{"tag":"盘后","latestPrice":21.92,"preClose":21.925,"latestTime":"19:05 EDT","volume":88718,"amount":1945130.084352,"timestamp":1714604739079},"delay":0,"floatShares":247364726,"shares":294799955,"eps":0.65,"marketStatus":"盘后交易","marketStatusCode":4,"change":-1.535,"latestTime":"05-01 19:26:54 EDT","open":21.64,"high":22.24,"low":20.69,"amount":160976565.001161,"amplitude":0.06607,"askPrice":23.88,"askSize":100,"bidPrice":21.77,"bidSize":13,"shortable":0,"etf":0,"ttmEps":0.65,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1714608000000},"adr":0,"listingDate":955425600000,"adjPreClose":23.46,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":21.64,"preClose":23.46,"latestTime":"09:26 EDT","volume":14230,"amount":331694.25615000003,"timestamp":1714570000027},"postHourTrading":{"tag":"盘后","latestPrice":21.92,"preClose":21.925,"latestTime":"19:05 EDT","volume":88718,"amount":1945130.084352,"timestamp":1714604739079},"volumeRatio":4.419666},"requestUrl":"/m/hq/s/EXEL/tweets","defaultTab":"tweets","newsList":[{"id":"2426265367","title":"伊克力西斯盘中异动 股价大跌5.07%报22.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426265367","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426265367?lang=zh_cn&edition=full","pubTime":"2024-04-11 22:16","pubTimestamp":1712844966,"startTime":"0","endTime":"0","summary":"北京时间2024年04月11日22时16分，伊克力西斯股票出现异动，股价急速跳水5.07%。截至发稿，该股报22.48美元/股，成交量49.46万股，换手率0.16%，振幅3.74%。最近的财报数据显示，该股实现营业收入18.30亿美元，净利润2.08亿美元，每股收益0.65美元，毛利17.58亿美元，市盈率34.62倍。伊克力西斯股票所在的生物技术行业中，整体跌幅为1.08%。该信息摘要如下：摩根大通证券公司：重申Exelixis评级，由优于大市调整至优于大市评级, 目标价27.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240411221607861e4ff3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240411221607861e4ff3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426852411","title":"摩根大通证券公司：重申Exelixis(EXEL.US)评级，由优于大市调整至优于大市评级, 目标价27.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2426852411","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2426852411?lang=zh_cn&edition=full","pubTime":"2024-04-10 23:14","pubTimestamp":1712762099,"startTime":"0","endTime":"0","summary":"摩根大通证券公司：重申Exelixis(EXEL.US)评级，由优于大市调整至优于大市评级, 目标价27.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404102315038b0ae805&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404102315038b0ae805&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2413933087","title":"伊克力西斯盘中异动 大幅上涨5.00%报21.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2413933087","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2413933087?lang=zh_cn&edition=full","pubTime":"2024-02-23 23:47","pubTimestamp":1708703269,"startTime":"0","endTime":"0","summary":"北京时间2024年02月23日23时47分，伊克力西斯股票出现波动，股价快速拉升5.00%。伊克力西斯股票所在的生物技术行业中，整体涨幅为0.87%。消息层面，截至23时47分，伊克力西斯股票正面舆情新闻比例100%。《伊克力西斯董事增持19万股普通股股份，价值约393.27万美元》资讯为影响伊克力西斯的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240223234749861d7f20&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240223234749861d7f20&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2409918273","title":"伊克力西斯2023财年实现净利润2.08亿美元，同比增加14.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2409918273","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2409918273?lang=zh_cn&edition=full","pubTime":"2024-02-07 23:27","pubTimestamp":1707319634,"startTime":"0","endTime":"0","summary":"12月31日，伊克力西斯公布财报，公告显示公司2023财年净利润为2.08亿美元，同比增加14.29%；其中营业收入为18.30亿美元，同比增加13.59%，每股基本收益为0.65美元。从资产负债表来看，伊克力西斯总负债7.32亿美元，其中短期债务25.72百万美元，资产负债比为4.10，流动比率为3.35。机构评级：截至2023年12月31日，当前有19家机构对伊克力西斯目标价做出预测，其中目标均价为26.79美元，其中最低目标价为18.00美元，最高目标价为32.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024020723271881763e5d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024020723271881763e5d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2409227686","title":"伊克力西斯盘中异动 早盘股价大跌5.27%报20.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2409227686","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2409227686?lang=zh_cn&edition=full","pubTime":"2024-02-07 22:30","pubTimestamp":1707316242,"startTime":"0","endTime":"0","summary":"北京时间2024年02月07日22时30分，伊克力西斯股票出现波动，股价大幅跳水5.27%。截至发稿，该股报20.68美元/股，成交量5.0077万股，换手率0.02%，振幅2.59%。最近的财报数据显示，该股实现营业收入18.30亿美元，净利润2.08亿美元，每股收益0.65美元，毛利17.58亿美元，市盈率31.82倍。机构评级方面，在所有20家参与评级的机构中，80%的券商给予买入建议，15%的券商给予持有建议，5%的券商给予卖出建议。伊克力西斯股票所在的生物技术行业中，整体跌幅为0.45%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024020722304287e6ed7e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024020722304287e6ed7e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2401952835","title":"伊克力西斯盘中异动 早盘股价大跌15.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2401952835","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2401952835?lang=zh_cn&edition=full","pubTime":"2024-01-08 22:31","pubTimestamp":1704724312,"startTime":"0","endTime":"0","summary":"北京时间2024年01月08日22时31分，伊克力西斯股票出现异动，股价快速跳水15.62%。截至发稿，该股报19.61美元/股，成交量22.8406万股，换手率0.07%，振幅4.82%。机构评级方面，在所有20家参与评级的机构中，80%的券商给予买入建议，15%的券商给予持有建议，5%的券商给予卖出建议。伊克力西斯股票所在的生物技术行业中，整体跌幅为0.93%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024010822315281a54ea7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024010822315281a54ea7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2382245247","title":"伊克力西斯2023财年第三财季实现净利润1.04百万美元，同比减少98.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2382245247","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2382245247?lang=zh_cn&edition=full","pubTime":"2023-11-10 00:24","pubTimestamp":1699547077,"startTime":"0","endTime":"0","summary":"9月30日，伊克力西斯公布财报，公告显示公司2023财年第三财季净利润为1.04百万美元，同比减少98.58%；其中营业收入为4.72亿美元，同比增加14.56%，每股基本收益为0.00美元。从资产负债表来看，伊克力西斯总负债6.29亿美元，其中短期债务0.00美元，资产负债比为4.74，流动比率为3.83。机构评级：截至2023年9月30日，当前有17家机构对伊克力西斯目标价做出预测，其中目标均价为25.82美元，其中最低目标价为18.00美元，最高目标价为32.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023111000244783ffb00e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023111000244783ffb00e&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.exelixis.com","stockEarnings":[{"period":"1week","weight":0.0073},{"period":"1month","weight":-0.0114},{"period":"3month","weight":0.0781},{"period":"6month","weight":0.1654},{"period":"1year","weight":0.2459},{"period":"ytd","weight":-0.0221}],"compareEarnings":[{"period":"1week","weight":-0.0073},{"period":"1month","weight":-0.0403},{"period":"3month","weight":0.0396},{"period":"6month","weight":0.1653},{"period":"1year","weight":0.2081},{"period":"ytd","weight":0.0561}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Exelixis, Inc.是一家生物科技公司，致力于研发癌症小分子治疗。公司于1994年11月在特拉华州注册为Exelixis制药股份有限公司，并于2000年2月改为Exelixis股份有限公司。公司的资源、研发、生产专注于COMETRIQ（卡博替尼胶囊，公司全资的多靶点受体酪氨酸激酶抑制剂）。公司目标是将COMETRIQ发展成一项主要的特许肿瘤经营产品，认为COMETRIQ治疗恶化、转移的MTC的批准给实现该目标、树立商业地位提供了一个机会。","yearOnYearQuotes":[{"month":1,"riseRate":0.541667,"avgChangeRate":0.018713},{"month":2,"riseRate":0.458333,"avgChangeRate":0.015199},{"month":3,"riseRate":0.541667,"avgChangeRate":-0.009275},{"month":4,"riseRate":0.541667,"avgChangeRate":0.053269},{"month":5,"riseRate":0.458333,"avgChangeRate":0.002702},{"month":6,"riseRate":0.541667,"avgChangeRate":0.025957},{"month":7,"riseRate":0.541667,"avgChangeRate":0.05138},{"month":8,"riseRate":0.416667,"avgChangeRate":-0.016155},{"month":9,"riseRate":0.458333,"avgChangeRate":-0.044733},{"month":10,"riseRate":0.541667,"avgChangeRate":-0.015438},{"month":11,"riseRate":0.583333,"avgChangeRate":0.058116},{"month":12,"riseRate":0.666667,"avgChangeRate":0.060039}],"exchange":"NASDAQ","name":"伊克力西斯","nameEN":"Exelixis"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"伊克力西斯(EXEL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供伊克力西斯(EXEL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"伊克力西斯,EXEL,伊克力西斯股票,伊克力西斯股票老虎,伊克力西斯股票老虎国际,伊克力西斯行情,伊克力西斯股票行情,伊克力西斯股价,伊克力西斯股市,伊克力西斯股票价格,伊克力西斯股票交易,伊克力西斯股票购买,伊克力西斯股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"伊克力西斯(EXEL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供伊克力西斯(EXEL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}